Clinical trial

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the…

NCT00463047 · Cephalon, Industry · Completed

Key facts

NCT number NCT00463047
Title Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
Official title A Randomized, Double-Blind, Active-Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compared With Immediate-release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patient With Chronic Pain
Lead sponsor Cephalon, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Chronic Pain
Intervention type Drug
Interventions Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone
Enrollment 323
Start date Jul 1, 2007
Primary completion Feb 1, 2009
Completion Feb 1, 2009
First posted Apr 19, 2007
Last update posted May 28, 2012
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies